Dong-A Pharmaceutical Launches Korea's First Liquid Sleep Aid "EasyQuil Night Act"

Rapid Absorption for Temporary Relief of Insomnia

Dong-A Pharmaceutical announced on December 4 that it has launched EasyQuil Night Act, the first liquid sleep aid in Korea.

EasyQuil Night Act. Dong-A Pharmaceutical

According to statistics from the National Health Insurance Service, the number of patients with sleep disorders exceeded 1.24 million in 2023. Sleep disorders can be caused by environmental factors such as irregular lifestyle habits, jet lag, and noise. If left untreated, they can worsen into chronic insomnia, making ongoing management essential.

EasyQuil Night Act stands for an Easy way to take the product for a Tranquil Night. Its main ingredient is diphenhydramine hydrochloride, a first-generation antihistamine. By crossing the blood-brain barrier (BBB) and acting on the central nervous system, it provides sleep-inducing and sedative effects. Compared to other sedative ingredients, it is less likely to cause tolerance and is characterized by minimal residual drowsiness the next day.

This is the first liquid formulation in Korea among products containing only diphenhydramine hydrochloride as the active ingredient, and it is absorbed by the body more rapidly than other forms. With added grape, plum, and lavender flavors, it can be consumed easily without discomfort. Individually packaged in pouches, it is convenient to take anytime and anywhere without water, and the recommended dosage is one pouch once a day.

A representative from Dong-A Pharmaceutical stated, "EasyQuil Night Act, the first liquid sleep aid in Korea, is quickly absorbed due to its liquid form and is easy to carry thanks to its pouch packaging. This allows those experiencing sleep difficulties to take it anytime, anywhere. Since continuous management is important for sleep disorders, we hope EasyQuil Night Act will help alleviate temporary insomnia symptoms."

This content was produced with the assistance of AI translation services.